A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Hummingbird Bioscience
Hummingbird Bioscience
Bristol-Myers Squibb
Fate Therapeutics
Alterome Therapeutics, Inc.
Verastem, Inc.
Revolution Medicines, Inc.
Pfizer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Incyte Corporation
Pfizer
Revolution Medicines, Inc.
PAQ Therapeutics, Inc.
Eli Lilly and Company
Servier
Eli Lilly and Company